North America market for digital genome is expected to rise with a CAGR of 9.75%
The United States dominates North America’s genome editing market. The high rate of adoption of advanced technology, the presence of big industry names, high funds for genomic research are all factors attributable to the major share of the country in this market.
Further, extensive research activities in genomics, gene editing, cell line culture, and modification are being conducted, which is boosting the market growth in the US. Several globally-renowned manufacturers of DNA sequencing technologies, equipment, and platforms are active in the US.
For instance, several prominent names in the DNA sequencing industry, such as Thermo Fisher Scientific,…